Voyager Therapeutics - 4 Year Stock Price History | VYGR
Historical daily share price chart and data for Voyager Therapeutics since 2015 adjusted for splits. The latest closing stock price for Voyager Therapeutics as of May 17, 2019 is 22.15.
- The all-time high Voyager Therapeutics stock price is 31.31, which is 41.4% above the current share price.
- The Voyager Therapeutics 52-week high stock price is 24.49, which is 10.6% above the current share price.
- The Voyager Therapeutics 52-week low stock price is 8.00, which is 63.9% below the current share price.
- The average Voyager Therapeutics stock price for the last 52 weeks is 16.64.
| Voyager Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2019 |
16.1183 |
9.4200 |
24.4900 |
8.0000 |
22.1500 |
135.64% |
| 2018 |
18.3287 |
17.6300 |
31.3100 |
8.5900 |
9.4000 |
-43.37% |
| 2017 |
12.6593 |
11.9700 |
25.8800 |
8.2400 |
16.6000 |
30.30% |
| 2016 |
12.5015 |
21.1500 |
21.1500 |
8.5600 |
12.7400 |
-41.83% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.816B |
$0.008B |
|
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
|
